Recent Progress in Bioconjugation Strategies for Liposome-Mediated Drug Delivery
Recent Progress in Bioconjugation Strategies for Liposome-Mediated Drug Delivery
About this item
Full title
Author / Creator
Publisher
Switzerland: MDPI AG
Journal title
Language
English
Formats
Publication information
Publisher
Switzerland: MDPI AG
Subjects
More information
Scope and Contents
Contents
In nanoparticle (NP)-mediated drug delivery, liposomes are the most widely used drug carrier, and the only NP system currently approved by the FDA for clinical use, owing to their advantageous physicochemical properties and excellent biocompatibility. Recent advances in liposome technology have been focused on bioconjugation strategies to improve d...
Alternative Titles
Full title
Recent Progress in Bioconjugation Strategies for Liposome-Mediated Drug Delivery
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_ac33ea301fe14af9acc58ac9f53eb9d6
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_ac33ea301fe14af9acc58ac9f53eb9d6
Other Identifiers
ISSN
1420-3049
E-ISSN
1420-3049
DOI
10.3390/molecules25235672
